Healthcare provider profile · identity verified

Erik Scott Powell, MD

Family Practice · MILFORD, OH · NPI 1245296540

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	134
Amlodipine Besylate	Amlodipine Besylate	306	89
Losartan Potassium	Losartan Potassium	301	89
Rosuvastatin Calcium	Rosuvastatin Calcium	292	79
Levothyroxine Sodium	Levothyroxine Sodium	268	58
Lisinopril	Lisinopril	253	55
Omeprazole	Omeprazole	201	51
Metformin Hcl	Metformin Hcl	191	53
Metoprolol Succinate	Metoprolol Succinate	155	42
Gabapentin	Gabapentin	142	29
Hydrochlorothiazide	Hydrochlorothiazide	131	38
Trazodone Hcl	Trazodone Hcl	122	30
Pantoprazole Sodium	Pantoprazole Sodium	110	34
Albuterol Sulfate Hfa	Albuterol Sulfate	97	33
Tamsulosin Hcl	Tamsulosin Hcl	95	25
Sertraline Hcl	Sertraline Hcl	91	30
Meloxicam	Meloxicam	88	19
Ozempic	Semaglutide	83	17
Simvastatin	Simvastatin	82	22
Eliquis	Apixaban	78	16
Fluticasone Propionate	Fluticasone Propionate	75	34
Donepezil Hcl	Donepezil Hcl	74	suppressed
Chlorthalidone	Chlorthalidone	64	22
Citalopram Hbr	Citalopram Hydrobromide	64	15
Jardiance	Empagliflozin	63	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	18
Famotidine	Famotidine	58	15
Furosemide	Furosemide	58	20
Metformin Hcl Er	Metformin Hcl	57	15
Carvedilol	Carvedilol	55	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	16
Alendronate Sodium	Alendronate Sodium	51	16
Fenofibrate	Fenofibrate	51	11
Trulicity	Dulaglutide	50	12
Allopurinol	Allopurinol	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	12
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	11
Oxybutynin Chloride Er	Oxybutynin Chloride	41	11
Pregabalin	Pregabalin	41	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Nifedipine Er	Nifedipine	37	14
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	12
Escitalopram Oxalate	Escitalopram Oxalate	34	12
Spironolactone	Spironolactone	34	11
Klor-Con M20	Potassium Chloride	32	12
Potassium Chloride	Potassium Chloride	32	11
Atenolol	Atenolol	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	14
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Ezetimibe	Ezetimibe	30	11
Glipizide Er	Glipizide	30	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Mounjaro	Tirzepatide	28	suppressed
Prednisone	Prednisone	28	23
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Ibuprofen	Ibuprofen	26	12
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Nitroglycerin	Nitroglycerin	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Finasteride	Finasteride	23	suppressed
Olanzapine	Olanzapine	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	15
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Naproxen	Naproxen	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Azithromycin	Azithromycin	18	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Valsartan	Valsartan	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Epinephrine	Epinephrine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error